Zyversa Therapeutics: Advancing Inflammation Control through Innovative Research Published in Frontiers in Immunology
Activation of Multiple Inflammasome Pathways in Neurodegenerative Diseases ZyVersa Therapeutics Announces Research Published in Frontiers in Immunology Activation of multiple inflammasome pathways contributes to pathological inflammation in neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS). A recent study has shown that NLRP3 inhibition alone was inadequate to address CNS inflammation in a mouse model of…